ANRO Stock Summary and Trading Ideas (Alto Neuroscience | NYSE:ANRO)

Alto Neuroscience Inc is a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individuals' neurobiology to develop personalized and effective treatment options. The company currently consists of different clinical-stage assets such as ALTO-100, ALTO-202, ALTO-101, and ALTO-300 among others initially targeting depressive disorders and schizophrenia populations as identified by independent brain-based biomarkers.

Alto Neuroscience trades on the NYSE stock market under the symbol ANRO.

As of October 17, 2024, ANRO stock price declined to $14.27 with 534,056 million shares trading.

ANRO has a beta of 2.26, meaning it tends to be more sensitive to market movements. ANRO has a correlation of 0.09 to the broad based SPY ETF.

ANRO has a market cap of $384.70 million. This is considered a Small Cap stock.

The top ETF exchange traded funds that ANRO belongs to (by Net Assets): VTI, IWM, VXF, IWO, SCHA.

ANRO support price is $13.67 and resistance is $15.23 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ANRO shares will trade within this expected range on the day.